Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Surgical Wound Infection 4Colorectal Neoplasms 4Neoplasms 3Sepsis 2Pancreatic Neoplasms 2Leukemia, Myeloid, Acute 2Febrile Neutropenia 2Triple Negative Breast Neoplasms 1Solitary Pulmonary Nodule 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Fistula 1Neutropenia 1Neoplasms, Plasma Cell 1Multiple Pulmonary Nodules 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lung Neoplasms 1Intestinal Neoplasms 1Inflammation 1Infections 1Glioblastoma 1Fever 1Exanthema 1Emergencies 1Duodenal Neoplasms 1Discitis 1Diarrhea 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Fulvestrant 2ruxolitinib 1dexpanthenol 1ceterizine hydrochloride 1capivasertib 1benralizumab 1Triamcinolone Acetonide 1Tetracycline 1Provitamins 1Prednisone 1Minocycline 1Loperamide 1Interviews as Topic 1Hydrocortisone 1HIV Testing 1Gels 1Fibroblast Growth Factor 7 1Erlotinib Hydrochloride 1Doxycycline 1Dapsone 1Clindamycin 1Cetuximab 1Anti-Bacterial Agents 1Alpelisib 1Acitretin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Exanthema × Anti-Bacterial Agents × Clear all
NCT01931150 2017-01-13

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
11 enrolled 7 charts
Gastrointestinal

Exanthema, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡